|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Comprehensive cervical cancer control, . A
guide to essential practice. World Health Organization. (Geneva,
Switzerland). 2006.
|
|
3
|
Burd EM: Human papillomavirus and cervical
cancer. Clin Microbiol Rev. 16:1–17. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Calin GA and Croce CM: MicroRNA-cancer
connection: The beginning of a new tale. Cancer Res. 66:7390–7394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu T, Liu K, Wu Y, Fan J, Chen ZJ, Li C,
Yang Q and Wang Z: MicroRNA-9 inhibits the proliferation of oral
squamous cell carcinoma cells by suppressing expression of CXCR4
via the Wnt/β-catenin signaling pathway. Oncogene. 33:5017–5027.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et
al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Si ML, Zhu S, Wu H, Lu Z, Wu F and Mo YY:
miR-21-mediated tumor growth. Oncogene. 26:2799–2803. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cho WC, Chow AS and Au JS: Restoration of
tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung
adenocarcinoma patients with epidermal growth factor receptor
mutation. Eur J Cancer. 45:2197–2206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kozomara A and Griffiths-Jones S: miRBase:
Annotating high confidence microRNAs using deep sequencing data.
Nucleic Acids Res. 42:D68–D73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang T, Wong HK, Gu W, Yu MY, To KF, Wang
CC, Wong YF, Cheung TH, Chung TK and Choy KW: MicroRNA-182 plays an
onco-miRNA role in cervical cancer. Gynecol Oncol. 129:199–208.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Denoyelle C, Lambert B, Meryet-Figuière M,
Vigneron N, Brotin E, Lecerf C, Abeilard E, Giffard F, Louis MH,
Gauduchon P, et al: miR-491-5p-induced apoptosis in ovarian
carcinoma depends on the direct inhibition of both BCL-XL and EGFR
leading to BIM activation. Cell Death Dis. 5:e14452014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakano H, Miyazawa T, Kinoshita K, Yamada
Y and Yoshida T: Functional screening identifies a microRNA,
miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal
cancer cells. Int J Cancer. 127:1072–1080. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo R, Wang Y, Shi WY, Liu B, Hou SQ and
Liu L: MicroRNA miR-491-5p targeting both TP53 and Bcl-XL induces
cell apoptosis in SW1990 pancreatic cancer cells through
mitochondria mediated pathway. Molecules. 17:14733–14747. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leivonen SK, Sahlberg KK, Mäkelä R, Due
EU, Kallioniemi O, Børresen-Dale AL and Perälä M: High-throughput
screens identify microRNAs essential for HER2 positive breast
cancer cell growth. Mol Oncol. 8:93–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan W, Zhang W, Sun L, Liu Y, You G, Wang
Y, Kang C, You Y and Jiang T: Identification of MMP-9 specific
microRNA expression profile as potential targets of anti-invasion
therapy in glioblastoma multiforme. Brain Res. 1411:108–115. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rutnam ZJ and Yang BB: The non-coding 3′
UTR of CD44 induces metastasis by regulating extracellular matrix
functions. J Cell Sci. 125:2075–2085. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang WC, Chan SH, Jang TH, Chang JW, Ko
YC, Yen TC, Chiang SL, Chiang WF, Shieh TY, Liao CT, et al:
miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral
squamous cell carcinoma invasion and metastasis. Cancer Res.
74:751–764. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Berry WL and Janknecht R: KDM4/JMJD2
histone demethylases: Epigenetic regulators in cancer cells. Cancer
Res. 73:2936–2942. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qi H, Jing Z, Xiaolin W, Changwu X,
Xiaorong H, Jian Y, Jing C and Hong J: Histone demethylase JMJD2A
inhibition attenuates neointimal hyperplasia in the carotid
arteries of balloon-injured diabetic rats via transcriptional
silencing: Inflammatory gene expression in vascular smooth muscle
cells. Cell Physiol Biochem. 37:719–734. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li BX, Li J, Luo CL, Zhang MC, Li H, Li
LL, Xu HF, Shen YW, Xue AM and Zhao ZQ: Expression of JMJD2A in
infiltrating duct carcinoma was markedly higher than fibroadenoma,
and associated with expression of ARHI, p53 and ER in infiltrating
duct carcinoma. Indian J Exp Biol. 51:208–217. 2013.PubMed/NCBI
|
|
21
|
Li BX, Zhang MC, Luo CL, Yang P, Li H, Xu
HM, Xu HF, Shen YW, Xue AM and Zhao ZQ: Effects of RNA
interference-mediated gene silencing of JMJD2A on human breast
cancer cell line MDA-MB-231 in vitro. J Exp Clin Cancer Res.
30:902011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kogure M, Takawa M, Cho HS, Toyokawa G,
Hayashi K, Tsunoda T, Kobayashi T, Daigo Y, Sugiyama M, Atomi Y, et
al: Deregulation of the histone demethylase JMJD2A is involved in
human carcinogenesis through regulation of the G(1)/S transition.
Cancer Lett. 336:76–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mallette FA and Richard S: JMJD2A promotes
cellular transformation by blocking cellular senescence through
transcriptional repression of the tumor suppressor CHD5. Cell Rep.
2:1233–1243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kauffman EC, Robinson BD, Downes MJ,
Powell LG, Lee MM, Scherr DS, Gudas LJ and Mongan NP: Role of
androgen receptor and associated lysine-demethylase coregulators,
LSD1 and JMJD2A, in localized and advanced human bladder cancer.
Mol Carcinog. 50:931–944. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hui Z, Yiling C, Wenting Y, XuQun H,
ChuanYi Z and Hui L: miR-491-5p functions as a tumor suppressor by
targeting JMJD2B in ERα-positive breast cancer. FEBS Lett.
589:812–821. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Berry WL, Shin S, Lightfoot SA and
Janknecht R: Oncogenic features of the JMJD2A histone demethylase
in breast cancer. Int J Oncol. 41:1701–1706. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rajwanshi VK, Håkansson AE, Sørensen MD,
Pitsch S, Singh SK, Kumar R, Nielsen P and Wengel J: The eight
stereoisomers of LNA (Locked Nucleic Acid): A remarkable family of
strong RNA binding molecules we acknowledge the Danish Natural
Science Research Council, the Danish Technical Research Council,
and Exiqon A/S for financial support. Ms Britta M. Dahl is thanked
for oligonucleotide synthesis, Dr. Carl E. Olsen for MALDI-MS
analysis, and Ms. Karen Jørgensen for recording CD spectra. Angew
Chem Int Ed Engl. 39:1656–1659. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shinoura N, Muramatsu Y, Nishimura M,
Yoshida Y, Saito A, Yokoyama T, Furukawa T, Horii A, Hashimoto M,
Asai A, et al: Adenovirus-mediated transfer of p33ING1 with p53
drastically augments apoptosis in gliomas. Cancer Res.
59:5521–5528. 1999.PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y,
Yao H, Liu X, Ke Y, Si J and Zhou T: MiR-375 frequently
downregulated in gastric cancer inhibits cell proliferation by
targeting JAK2. Cell Res. 20:784–793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gong F, Ren P, Zhang Y, Jiang J and Zhang
H: MicroRNAs-491-5p suppresses cell proliferation and invasion by
inhibiting IGF2BP1 in non-small cell lung cancer. Am J Transl Res.
8:485–495. 2016.PubMed/NCBI
|
|
32
|
Xu Y, Hou R, Lu Q, Zhang Y, Chen L, Zheng
Y and Hu B: MiR-491-5p negatively regulates cell proliferation and
motility by targeting PDGFRA in prostate cancer. Am J Cancer Res.
7:2545–2553. 2017.PubMed/NCBI
|
|
33
|
Sun R, Liu Z, Tong D, Yang Y, Guo B, Wang
X, Zhao L and Huang C: miR-491-5p, mediated by Foxi1, functions as
a tumor suppressor by targeting Wnt3a/β-catenin signaling in the
development of gastric cancer. Cell Death Dis. 8:e27142017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Black JC, Manning AL, Van Rechem C, Kim J,
Ladd B, Cho J, Pineda CM, Murphy N, Daniels DL, Montagna C, et al:
KDM4A lysine demethylase induces site-specific copy gain and
rereplication of regions amplified in tumors. Cell. 154:541–555.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu CE, Liu YC, Zhang HD and Huang GJ:
JMJD2A predicts prognosis and regulates cell growth in human
gastric cancer. Biochem Biophys Res Commun. 449:1–7. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li X, Liu Y, Granberg KJ, Wang Q, Moore
LM, Ji P, Gumin J, Sulman EP, Calin GA, Haapasalo H, et al: Two
mature products of MIR-491 coordinate to suppress key cancer
hallmarks in glioblastoma. Oncogene. 34:1619–1628. 2015. View Article : Google Scholar : PubMed/NCBI
|
